(Reuters) - Momenta Pharmaceuticals Inc said the U.S. Food and Drug Administration approved the first generic version of Teva Pharmaceuticals Industries Ltd's top-selling multiple sclerosis drug, Copaxone.
via Reuters: Health News Read More Here..
No comments:
Post a Comment